시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 신경 수복 및 재생 시장 보고서(2025년)
Nerve Repair And Regenerative Global Market Report 2025
상품코드 : 1824419
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신경 수복 및 재생 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 11.7%로 성장할 전망이며, 170억 2,000만 달러로 성장이 예측됩니다. 예측 기간의 성장 배경으로는 줄기세포 치료에 대한 주목, 스포츠에 의한 신경 손상 증가, 유전자 치료 접근법의 개발, 희귀질환에 대한 정부의 이니셔티브, 환자 중심의 헬스케어 모델 등이 있습니다. 예측 기간 주요 동향으로는 신경자극 기술의 진보, 신경 재생에서 줄기세포의 이용, 신경 수복에서 나노 기술, 협동 및 파트너십, 생물공학 및 로봇의 통합 등을 들 수 있습니다.

향후 5년간의 성장률 11.7%라고 하는 예측은 전회 예측으로부터 0.1%라고 하는 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 관세 장벽은 스위스나 한국에서 조달하는 신경 유도도관과 신경 영양인자의 비용을 상승시키고, 말초신경의 회복을 늦추며, 신경외과의 재활비용을 상승시킴으로써 미국을 방해할 것으로 예측됩니다. 또한 상호관세와 무역 긴장 증가 및 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더욱 광범위해질 것으로 보입니다.

신경 수복 및 재생 시장의 예상 성장은 신경 장애의 발생 건수 증가에 의해 촉진될 것으로 예측됩니다. 신경 질환은 뇌, 척수, 말초 신경을 포함한 신경계에 영향을 미치는 상태와 질병을 포함합니다. 신경 장애 발생률 상승의 요인으로는 고령화 인구 확대, 라이프스타일의 변화, 유전적 요인, 앉아만 있는 행동 등을 들 수 있습니다. 신경 수복 및 재생 기술은 손상된 신경의 치유와 재생을 촉진하고 회복 가능성을 향상시키며 신경 장애의 유병률을 감소시키는 것을 목표로 합니다. 그 두드러진 예가 간질의 세계적인 영향입니다. 간질은 가장 만연한 신경 질환 중 하나이며 세계 5,000만 명 이상이 앓고 있습니다. 이것은 신경 질환의 광범위한 영향력과 신경 수복 및 재생 시장의 성장에 기여를 강조합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Nerve repair and regeneration refer to the process of restoring damaged or injured nerves to their normal function. This process is utilized to repair or regenerate the structures and pathways of nerves affected by trauma, disease, or other conditions. Furthermore, effective repair aims to minimize scar tissue formation, which can impede regeneration and contribute to chronic pain or dysfunction.

Key products in the field include biomaterials and neurostimulation/neuromodulation devices. Biomaterials, whether synthetic or natural, are meticulously designed substances engineered to interact with biological systems, including cells, tissues, and organs. Possessing specific physical, chemical, and biological properties, biomaterials facilitate healing, regeneration, and functional restoration in the body. Nerve repair and regenerative procedures encompass various techniques such as direct nerve repair (neurorrhaphy), nerve grafting, stem cell therapy, and neurostimulation/neuromodulation surgeries. These interventions find application in diverse healthcare settings, including hospitals, clinics, ambulatory surgical centers (ASCs), research and academic institutions, specialty clinics, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nerve repair and regenerative market research report is one of a series of new reports from The Business Research Company that provides nerve repair and regenerative market statistics, including the nerve repair and regenerative industry's global market size, regional shares, competitors with a nerve repair and regenerative market share, detailed nerve repair and regenerative market segments, market trends, and opportunities, and any further data you may need to thrive in the nerve repair and regenerative industry. This nerve repair and regenerative market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nerve repair and regenerative market size has grown strongly in recent years. It will grow from $9.97 billion in 2024 to $10.95 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increased incidence of nerve injuries, aging population and neurodegenerative diseases, rise in peripheral nerve surgeries, growth in awareness and diagnosis rates, and patient preferences for minimally invasive procedures.

The nerve repair and regenerative market size is expected to see rapid growth in the next few years. It will grow to $17.02 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to a focus on stem cell therapies, an increase in sports-related nerve injuries, the development of gene therapy approaches, government initiatives for rare diseases, and patient-centric healthcare models. Major trends in the forecast period include advancements in neurostimulation technologies, the use of stem cells for nerve regeneration, nanotechnology in nerve repair, collaborations and partnerships, and the integration of bioengineering and robotics.

The forecast of 11.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of nerve guidance conduits and neurotrophic factors sourced from Switzerland and South Korea, thereby delaying peripheral nerve recovery and elevating neurosurgical rehabilitation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth of the nerve repair and regenerative market is expected to be propelled by the increasing incidences of neurological disorders. Neurological disorders encompass conditions or diseases affecting the nervous system, including the brain, spinal cord, and peripheral nerves. Factors contributing to the rising incidences of neurological disorders include the expanding aging population, lifestyle changes, genetic factors, and sedentary behaviors. Nerve repair and regenerative techniques aim to facilitate healing and regeneration of damaged nerves, improving recovery prospects and reducing the prevalence of neurological disorders. A notable example is the global impact of epilepsy, recognized as one of the most prevalent neurological disorders, affecting over 50 million individuals worldwide, with approximately 80% of cases found in low- and middle-income countries. This underscores the widespread influence of neurological disorders and their contribution to the growth of the nerve repair and regenerative market.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the nerve repair and regenerative market in the future. Chronic diseases, such as diabetes, cancer, and arthritis, last for more than a year and require ongoing medical attention. The growing prevalence of chronic diseases worldwide expands the patient population that needs effective nerve repair and regenerative solutions. For example, in January 2022, the American Cancer Society, a US-based cancer awareness non-profit organization, estimated that the US would see approximately 1.9 million new cancer cases and 609,360 cancer-related deaths, equating to about 1,670 deaths daily. Therefore, the rising prevalence of chronic diseases is fueling the growth of the nerve repair and regenerative market.

The nerve repair and regenerative market are currently witnessing a significant trend in product innovation, with major players focusing on the development of novel products to enhance their market positions. A notable example of this trend is Abbott, a US-based medical device company, which received approval from the United States FDA in August 2022 for its ProClaim plus spinal cord stimulation system featuring FlexBurst therapy. This innovative system is designed to alleviate chronic pain associated with various conditions, including specific nerve-related disorders. The ProClaim Plus system stands out by offering the capability to treat multi-site pain, allowing physicians to target multiple pain sites and address complex pain patterns associated with certain neurological disorders. This FDA approval represents a milestone in pain management, aiming to improve the quality of life by reducing pain and enhancing overall well-being.

Many companies in the nerve repair and regenerative market are strategically partnering and collaborating with others to expand their product portfolios and enhance their regenerative medicine businesses. These collaborations are enabling nerve repair and regenerative manufacturing companies to improve their competitiveness in specific therapy areas. For instance, in March 2022, Integra LifeSciences Holding Corporation, a US-based medical device company, launched the NeuraGen 3D Nerve Guide Matrix. This resorbable implant is specifically designed for repairing peripheral nerve discontinuities and combines trusted bovine type 1 collagen with the Integra Dermal Regeneration Template to create an optimized healing environment. The product features a unique inner matrix with porous channels that promote Schwann cell migration and axonal growth, enhancing functional recovery after mid-gap nerve repair compared to traditional hollow conduits. This innovative solution represents a significant advancement in peripheral nerve repair technology.

In October 2022, Collagen Matrix, Inc., a US-based regenerative medicine provider, acquired Polyganics for an undisclosed amount. This acquisition aimed to enhance Collagen Matrix's product portfolio by integrating Polyganics' innovative solutions in nerve and dura repair, further solidifying its position in the regenerative medicine sector. The deal aligns with Collagen Matrix's strategy to expand its reach and capabilities in developing medical devices for tissue regeneration. Polyganics is a Netherlands-based medical technology company that develops nerve repair products such as VIVOSORB.

Major companies operating in the nerve repair and regenerative market include Neuronetics Inc., Abbott Laboratories, Medtronic PLC., Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, LivaNova PLC, Nevro Corporation, Medartis Holding AG, AxoGen Inc., NeuroPace Inc., BioWave Corporation, Soterix Medical Inc., Checkpoint Surgical Inc., Synapse Biomedical Inc., Nuvectra Corp., Synovis Micro Companies Alliance Inc., NeuroSigma, Regenity Biosciences, Epineuron Technologies Inc.

North America was the largest region in the nerve repair and regenerative market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nerve repair and regenerative market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nerve repair and regenerative market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nerve repair and regenerative market consists of revenues earned by entities by providing services such as medical consultations, diagnosis, surgical procedures, follow-up care, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nerve repair and regenerative market also includes sales of surgical instruments, nerve grafts, nerve conduits, biocompatible materials, bioactive scaffolds, and other regenerative medicine products.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nerve Repair And Regenerative Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nerve repair and regenerative market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nerve repair and regenerative ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nerve repair and regenerative market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Nerve Repair And Regenerative Market Characteristics

3. Nerve Repair And Regenerative Market Trends And Strategies

4. Nerve Repair And Regenerative Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nerve Repair And Regenerative Growth Analysis And Strategic Analysis Framework

6. Nerve Repair And Regenerative Market Segmentation

7. Nerve Repair And Regenerative Market Regional And Country Analysis

8. Asia-Pacific Nerve Repair And Regenerative Market

9. China Nerve Repair And Regenerative Market

10. India Nerve Repair And Regenerative Market

11. Japan Nerve Repair And Regenerative Market

12. Australia Nerve Repair And Regenerative Market

13. Indonesia Nerve Repair And Regenerative Market

14. South Korea Nerve Repair And Regenerative Market

15. Western Europe Nerve Repair And Regenerative Market

16. UK Nerve Repair And Regenerative Market

17. Germany Nerve Repair And Regenerative Market

18. France Nerve Repair And Regenerative Market

19. Italy Nerve Repair And Regenerative Market

20. Spain Nerve Repair And Regenerative Market

21. Eastern Europe Nerve Repair And Regenerative Market

22. Russia Nerve Repair And Regenerative Market

23. North America Nerve Repair And Regenerative Market

24. USA Nerve Repair And Regenerative Market

25. Canada Nerve Repair And Regenerative Market

26. South America Nerve Repair And Regenerative Market

27. Brazil Nerve Repair And Regenerative Market

28. Middle East Nerve Repair And Regenerative Market

29. Africa Nerve Repair And Regenerative Market

30. Nerve Repair And Regenerative Market Competitive Landscape And Company Profiles

31. Nerve Repair And Regenerative Market Other Major And Innovative Companies

32. Global Nerve Repair And Regenerative Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nerve Repair And Regenerative Market

34. Recent Developments In The Nerve Repair And Regenerative Market

35. Nerve Repair And Regenerative Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기